What You Should Know:
- ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.
- ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
Vytalize Health Closes $100M to Support Value-Based Care Transformation
What You Should Know:
- Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in funding led by Enhanced Healthcare Partners and Monroe Capital, with participation from North Coast Ventures.
- Vytalize Health partners with primary care practices for more than 250,000 patients and offers evidence-based recommendations at the point of care. By delivering the right data at the right time in the workflow to physicians and their staff,
Read More
BrightInsight Adds ixlayer to BrightInsight Ecosystem to Improve Therapy Matching
What You Should Know:
- BrightInsight announced that ixlayer has joined the BrightInsight Ecosystem, a network of more than 20 of the world’s leading healthcare and technology companies driving growth and adoption of digital health solutions.
- The BrightInsight Ecosystem of partners collaborates to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement.
Why It Matters
Conditions such as high cholesterol, autoimmune
Read More
Indegene Launches Metaverse Capabilities for Life Sciences Companies
What You Should Know:
- Indegene, a digital-first, life sciences commercialization company launches metaverse capabilities to support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education.
- Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds. Using these, life
Read More
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
What You Should Know:
- Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials.
As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More
Ascensia Diabetes Care Partners with SNAQ to Support Mealtime Decision-Making
What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs).
- As part of the strategic collaboration, Ascensia and SNAQ will integrate their solutions to empower more PWDs to make impactful mealtime decisions, with a goal to improve diabetes management.
Support Mealtime Decision-Making
Read More
Bluestem Health Launches AI-Based Virtual Healthcare Assistant Powered by Mediktor
What You Should Know:
- Nebraska-based Bluestem Health today announced it has launched an AI-based virtual medical assistant powered by Mediktor. This is available for both established and non-established patients to efficiently assess their symptoms online and direct them to the appropriate level of care.
- Mediktor combines AI, Natural Language Processing (NLP) and machine learning technologies for the first clinically validated digital medical assistant, proven in clinical trials with
Read More
How and Why Device-as-a-Service Should Be an Employee Benefit
The Great Resignation changed how companies approach attracting and retaining talent. These days, it’s not enough to offer a competitive salary and traditional benefits like health insurance and a 401k. Employees have put an increased focus on flexibility – and the tools that support it.
Phones and tablets aren’t the flashiest perk a company can offer. Still, they’re the type of lifestyle benefit that offers clear value for employees – and helps address pain points for companies
Read More
5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials
In the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the
Read More
